Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Corticotherapy in Pemphigus (Ritux 3)
NCT00784589Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Jul 2009
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in pemphigus vulgaris (PV), pemphigus foliaceus (PF), sponsored by Rouen University Hospital. Started Jul 2009; status: completed.
02
Drugs
rituximab
03
Conditions
pemphigus vulgaris (PV)pemphigus foliaceus (PF)
Beyond the preview
Go deeper on NCT00784589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784589.